Obesity, Inflammation, and Insulin Resistance – A Mini-Review

Gerontology - Tập 55 Số 4 - Trang 379-386 - 2009
Maximilian Zeyda1, Thomas M. Stulnig
1Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria

Tóm tắt

The association of obesity, insulin resistance, and chronic low-grade inflammation has been evident for several years by now. Since obesity, insulin resistance, and inflammation all are related to aging as well, the mechanisms underlying this association are of critical importance for gerontology. Although several molecular and cellular mechanisms by which inflammatory events decrease the sensitivity to insulin in obese patients have recently been elucidated, the pathogenesis of obesity-induced insulin resistance is still obscure in many aspects. This review aims at giving a general view on the known mechanisms and summarizing the recent progress. Research currently focuses on adipose tissue inflammation as predominantly driven by adipose tissue macrophages, but also related alterations in other organs (liver, muscle, pancreas) have to be considered. Moreover, novel approaches for treatment and prevention of insulin resistance and type 2 diabetes by targeting obesity-induced inflammatory processes are discussed here.

Từ khóa


Tài liệu tham khảo

10.1159%2F000161734

10.1038%2F27376

10.1210%2Fen.2007-1312

10.1016%2FS0889-8561%2802%2900056-5

10.1196%2Fannals.1372.001

10.1126%2Fscience.7678183

10.1038%2F39335

10.1126%2Fscience.271.5249.665

10.1074%2Fjbc.M403886200

10.1210%2Fen.2006-0692

10.1074%2Fjbc.M509782200

10.1007%2Fs00125-008-0998-8

10.1152%2Fjapplphysiol.01208.2006

10.1038%2Fnm1185

10.1152%2Fajprenal.00161.2007

10.1126%2Fscience.1103160

10.1126%2Fscience.1128294

10.1016%2Fj.bbrc.2007.07.176

10.1161%2FCIRCULATIONAHA.107.717595

10.1016%2FS0083-6729%2806%2974018-3

10.1038%2Fsj.ijo.0803632

10.2337%2Fdb06-0133

10.1194%2Fjlr.M500294-JLR200

10.1210%2Fjc.2007-2630

10.1172%2FJCI26498

10.2337%2Fdb07-0425

10.1172%2FJCI24335

10.2337%2Fdb06-1076

10.1016%2Fj.imlet.2007.07.003

10.1007%2Fs00125-006-0300-x

10.1172%2FJCI29881

10.1096%2Ffj.04-2204com

10.1172%2FJCI28898

10.2337%2Fdb06-1491

10.1016%2Fj.mad.2003.08.002

10.1074%2Fjbc.M708568200

10.1007%2Fs00125-007-0654-8

10.1073%2Fpnas.0707849104

10.1016%2Fj.cmet.2008.04.003

10.1080%2F13813450600711540

10.1172%2FJCI31561

10.2337%2Fdb07-1356

10.1161%2FCIRCRESAHA.106.142851

10.2337%2Fdb06-1650

10.1096%2Ffj.07-101824

10.1172%2FJCI200215318

10.2337%2Fdc07-1338

10.1124%2Fmol.107.039479

10.1210%2Fjc.2004-0446

10.1136%2Fgut.2007.134288

10.1073%2Fpnas.0607626103

10.1038%2Fnature05894

10.1038%2Fsj.ijo.0803511

10.2337%2Fdiabetes.55.04.06.db05-0985

10.1159%2F000090951

10.1159%2F000074898

10.1038%2Fnature05354

10.1016%2Fj.jnutbio.2007.02.010